CSL Limited
CSL
Rankning i aktier
#364
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Aktiekurs
$138.43
Marknadsvärde
$66.43B
Förändring (1 dag)
-0.14%
Förändring (1 år)
-3.24%
Land
AU
Handel CSL Limited (CSL)
Kategori
Healthcare
Historik för aktiesplit för CSL Limited (CSL)
Aktien CSL Limited (symbol: CSL) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Oct 18, 2007.
En CSL-aktie köpt före Oct 18, 2007 motsvarar nu 3 CSL-aktier.
Den senaste spliten skedde den Oct 18, 2007.
En CSL-aktie köpt före Oct 18, 2007 motsvarar nu 3 CSL-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| 2007-10-18 | 3:1 | x3 | x3 |
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
|
| 1 | x100 |
BE
|
